Blinklab (ASX:BB1)
ASX announcement history & article coverage
Transparent by design.
Announcments by Blinklab (ASX:BB1) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Section 708A Notice
Application for quotation of securities - BB1
Initial Director's Interest Notice
Final Director's Interest Notice
Notification regarding unquoted securities - BB1
Former Apple Health Clinical Lead Appointed to the Board
Results of AGM
Corporate Presentation Update
Resignation and Appointment of Auditor
Investor Webinar - Positive European ADHD Study Results
European ADHD Study Delivers Positive Results
Letter to Shareholders & Proxy Form
Notice of Annual General Meeting & Proxy Form
Trading Halt
Appendix 4G & Corporate Governance Statement
2026 Annual Report & Appendix 4E
BlinkLab reports revenue growth, increased loss, advances AI diagnostics, raises $17.5M capital
BlinkLab to Present at TechKnow Invest Roadshow
Quarterly Activities/Appendix 4C Cash Flow Report
BlinkLab raises A$17.5M, secures US patent, advances FDA autism study and ADHD research
Change of Director's Interest Notice x4
Company Update on Clinical Development Programs
Section 708A Notice
Notification regarding unquoted securities - BB1
Application for quotation of securities - BB1
Application for quotation of securities - BB1
Notification regarding unquoted securities - BB1
European ADHD Study Update
Results of General Meeting
BB1 Granted Foundational U.S. Patent
BB1 Partners with ESPOCH on Large-Scale Multicenter Program